Ming Chen

15PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 07, 2024
TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial.

Baiqiang Dong, Long Chen, Qingsong Pang

|Jul 11, 2024
Safety and short-term outcomes of esophagectomy after neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell cancer: analysis of two phase-II clinical trials.

Dijian Shen, Runzhe Chen, Qing Wu

|Mar 06, 2024
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial.

Shuzhen Lai, Peijing Li, Xiaohui Liu

|Oct 06, 2023
PI3K/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer.

Huan Deng, Yamei Chen, Li Wang

|Feb 22, 2022
A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma.

Yujin Xu, Baiqiang Dong, Weiguo Zhu

|Jan 08, 2022
Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review.

Yamei Chen, Ying Jin, Xiao Hu

Pageof 3

Frequent Collaborators

3 joint publications

Yuanyuan Chen

2 joint publications

Zhengbo Song

2 joint publications

Baiqiang Dong

1 joint publications

Li Qinglin